Research study Program year 2023 Source: CMS Open Payments

Lmd-002

ClinicalTrials.gov NCT05070364

Research payments

$138,075

8 payments

Through program year 2023, $138,075 in research payments was reported against Lmd-002, across 8 payments, paid by Eiger BioPharmaceuticals, Inc..

Paid by: Eiger BioPharmaceuticals, Inc.
ClinicalTrials.gov: NCT05070364

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$138,075	8

Breakdown

Who paid Research payments · program year 2023

Eiger BioPharmaceuticals, Inc. $138,075 8 payments

Who received the money Research payments · program year 2023

1 Organisation paid for research $138,075 8 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2023

Professional salary support $138,075 8 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.